chr18-13029948-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032142.4(CEP192):āc.1336A>Gā(p.Thr446Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000406 in 1,551,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032142.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP192 | NM_032142.4 | c.1336A>G | p.Thr446Ala | missense_variant | 10/45 | ENST00000506447.5 | NP_115518.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP192 | ENST00000506447.5 | c.1336A>G | p.Thr446Ala | missense_variant | 10/45 | 5 | NM_032142.4 | ENSP00000427550.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000130 AC: 2AN: 153916Hom.: 0 AF XY: 0.0000245 AC XY: 2AN XY: 81688
GnomAD4 exome AF: 0.0000336 AC: 47AN: 1399284Hom.: 0 Cov.: 31 AF XY: 0.0000333 AC XY: 23AN XY: 690128
GnomAD4 genome AF: 0.000105 AC: 16AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2023 | The c.1336A>G (p.T446A) alteration is located in exon 10 (coding exon 9) of the CEP192 gene. This alteration results from a A to G substitution at nucleotide position 1336, causing the threonine (T) at amino acid position 446 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at